Caprion Biosciences Expands its Biomarker and Immune Monitoring Franchise by Acquiring US-Based Primity Bio

Caprion Biosciences announced today that the company acquired Primity Bio Inc., a specialized provider of biomarker and immune monitoring services located in Fremont, California. Caprion will leverage Primity’s strong technological capabilities and innovative track record to further expand its immunology and molecular profiling service offering as well as its ability to globally support its clients.

Source
News Wire
Language
English

Read More